MDLOX
Price
$20.51
Change
+$0.01 (+0.05%)
Updated
Oct 17 closing price
Net Assets
17.02B
RLEFX
Price
$38.98
Change
+$0.04 (+0.10%)
Updated
Oct 17 closing price
Net Assets
265.37B
Interact to see
Advertisement

MDLOX vs RLEFX

Header iconMDLOX vs RLEFX Comparison
Open Charts MDLOX vs RLEFXBanner chart's image
BlackRock Global Allocation Inv A
Price$20.51
Change+$0.01 (+0.05%)
VolumeN/A
Net Assets17.02B
American Funds American Balanced R5E
Price$38.98
Change+$0.04 (+0.10%)
VolumeN/A
Net Assets265.37B
MDLOX vs RLEFX Comparison Chart in %
View a ticker or compare two or three
VS
MDLOX vs. RLEFX commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MDLOX is a StrongBuy and RLEFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLEFX has more cash in the bank: 265B vs. MDLOX (17B). MDLOX pays higher dividends than RLEFX: MDLOX (2.48) vs RLEFX (1.92). MDLOX was incepted earlier than RLEFX: MDLOX (31 years) vs RLEFX (10 years). MDLOX (1.14) is less costly to investors than RLEFX (0.39). MDLOX is a more actively managed with annual turnover of: 138.00 vs. RLEFX (44.00). RLEFX has a lower initial minimum investment than MDLOX: RLEFX (250) vs MDLOX (1000). RLEFX annual gain was more profitable for investors over the last year : 8.94 vs. MDLOX (7.67). RLEFX return over 5 years is better than : 43.26 vs. MDLOX (4.83).
MDLOXRLEFXMDLOX / RLEFX
Total Expense Ratio1.110.39285%
Annual Report Gross Expense Ratio1.140.39292%
Fund Existence31 years10 years-
Gain YTD12.44214.81984%
Front Load5%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets17B265B6%
Annual Yield % from dividends2.481.92129%
Returns for 1 year7.678.9486%
Returns for 3 years35.4351.3969%
Returns for 5 years4.8343.2611%
Returns for 10 years13.20N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
COEP15.380.38
+2.53%
Coeptis Therapeutics Holdings Inc
STC69.760.91
+1.32%
Stewart Information Services Corp
ATMVU22.00N/A
N/A
AlphaVest Acquisition Corp
BBIO54.92-0.11
-0.20%
BridgeBio Pharma
SRTA4.99-0.09
-1.77%
Strata Critical Medical Inc